Kolexia
Marques Ana
Neurologie
Hôpital Gabriel Montpied
Clermont-Ferrand, France
158 Activités
369 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Parkinson Trouble du comportement en sommeil paradoxal Syndrome des jambes sans repos Hallucinations Illusions Atrophie Tremblement Tremblement essentiel Intolérance au glucose

Industries

Abbvie
12 collaboration(s)
Dernière en 2023
Pharma Dom
6 collaboration(s)
Dernière en 2023
Aguettant
3 collaboration(s)
Dernière en 2023
LVL Medical
2 collaboration(s)
Dernière en 2022

Dernières activités

LUMA: A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Essai Clinique (Biogen)   15 mars 2024
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Essai Clinique (CHDI Foundation, Inc.)   26 février 2024
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.
Journal of neurology   09 février 2024
PERSO-PERF: Could Psycho-bio-social Context and Personality be a Predictive Factor of Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease Patients? - PERSO-PERF Study
Essai Clinique (CHU Toulouse)   30 janvier 2024
METABO-NGC-7T: Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
Essai Clinique (CHU Clermont-Ferrand)   26 janvier 2024
ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry   25 janvier 2024
Botulinum Toxin for Isolated or Essential Head Tremor. Reply.
The New England journal of medicine   25 janvier 2024
Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study.
Journal of neurology   12 janvier 2024
New ICD-11 diagnostic criteria for chronic secondary musculoskeletal pain associated with Parkinson disease.
Pain   11 janvier 2024
Trial of Botulinum Toxin for Isolated or Essential Head Tremor.
The New England journal of medicine   09 novembre 2023